Diet Pill Supplement OxyElite Linked to Liver Failure

OxyElite Pro

Health officials are asking stores to pull a fat-burning supplement from shelves after officials linked it to cases of liver failure and acute hepatitis in 29 people.

Two people have undergone liver transplants and one person has died, according to the Hawaii State Department of Health. Twenty-four of the people who fell ill reported using OxyElite Pro before being diagnosed; the patients had no other medication or supplement in common.

While the investigation is ongoing, health officials advised people to “discontinue use of the product at this time.” Hawaii investigators are working with the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention.

“Anyone who develops symptoms such as abdominal pain or discomfort, fatigue, loss of appetite, nausea and/or vomiting, and yellow skin or eyes should consult their doctor immediately,” Health Director Loretta Fuddy said in a statement.

OxyElite Pro is sold nationwide. Because it is a dietary supplement, it did not have to be approved by the FDA before going to market.

USPlabs, the company that produces OxyElite Pro, said it stands by the safety of all its products, but “out of an abundance of caution,” the company is stopping domestic distribution of OxyElite Pro with the purple top and OxyElite Pro Super Thermo Powder.

“The company continues to believe these versions are safe and are not the cause of the cluster of liver toxicity that has occurred in Hawaii,” USPlabs said in a statement.

USPlabs informed the FDA that counterfeit versions of OxyElite Pro have been circulating in the United States, according to an advisory issued by the FDA. The agency is investigating whether counterfeit products are linked to any of the hepatitis cases.

USPlabs once also produced a product called OxyElite Pro with DMAA, but that has not been manufactured or distributed since earlier this year, the company said.

In April, the FDA said it was using “all available tools at its disposal” to eliminate supplements containing the stimulant dimethylamylamine, or DMAA, from the market. The agency said DMAA can cause increased blood pressure, shortness of breath, chest tightening, cardiovascular problems and even heart attacks.

FDA spokeswoman Tamara Ward told CNN at the time that 11 companies had received warning letters from the FDA over the past year asking them to stop marketing products that contain DMAA. All but one — USPlabs — agreed to stop using DMAA in supplements.

– CNN Health update

CDC Sounds Alarm on Antibiotic-Resistant Bacteria

Report cites overuse of antibiotics as key to the life-threatening problem.

info by Dennis Thompson, HealthDay News
medicine_2111168b-1

MONDAY, Sept. 16 (HealthDay News)  More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday by federal health officials.

The report marks the first time that the U.S. Centers for Disease Control and Prevention has performed a comprehensive analysis of the impact on society from antibiotic-resistant bacteria, said Dr. Steve Solomon, director of the agency’s Office of Antimicrobial Resistance.

“This is scary stuff, and we want people to know about it,” he said.

The report outlines how antibiotic resistance occurs in patients and spreads through the community. It also lists medical procedures that have become more dangerous because of these bacteria. Those procedures include dialysis, chemotherapy, complex surgery and organ transplants.

Antibiotic overuse is the single most important factor leading to antibiotic resistance, according to the report. Antibiotics are among the most commonly prescribed drugs, but as many as half of those prescriptions are either not needed or not the best course of treatment for the patient, the report said.

“Patients need to understand that antibiotics are not the solution for every illness,” Solomon said. “It’s important that people not take antibiotics when they aren’t necessary. It contributes to resistance, and it also has consequences to the patient in the form of side effects.”

The CDC also faulted the use of antibiotics in food animals to prevent, control and treat disease, and to promote their growth. “The use of antibiotics for promoting growth is not necessary, and the practice should be phased out,” the report stated.

The centerpiece of the CDC report is a threat-level assessment for 18 bacteria- and antibiotic-related illnesses, broken down into three categories: urgent, serious and concerning.

Three antibiotic-related illnesses are ranked as urgent threats demanding immediate attention:

  • Carbapenem-resistant Enterobacteriaceae , or CRE, are a family of bacteria that have developed remarkable drug resistance in recent years. Half the people who get bloodstream infections from CRE die. About 9,300 hospital infections of CRE occur each year. “A lot of those bacteria are becoming resistant to every antibiotic we have,” Solomon said of CRE. “We are very concerned about significant spread over the next few years.”
  • Neisseria gonorrhoeae — the bacteria that causes gonorrhea — are showing signs of resistance to the cephalosporin family of antibiotics. The CDC estimated that about one-third of the 820,000 annual gonorrhea infections involve strains that have become antibiotic-resistant. “The cephalosporins are really the last line of defense we have against gonorrhea,” Solomon said. “It has shown its ability to become resistant to every antibiotic we throw at it. If we lost those — if this cephalosporin-resistant gonorrhea spreads — that disease is going to be untreatable.”
  • Clostridium difficile is bacteria that, although not antibiotic resistant, poses an urgent threat because it causes diarrhea linked to at least 250,000 hospitalizations and 14,000 American deaths each year. C. difficile infections occur because of antibiotic use that destroys the good bacteria in people’s bodies that protect against illness. “Because there has not been as much success in addressing the problem of antibiotic overuse, we are flagging that as an urgent problem because it has to be brought under control,” Solomon said.

Twelve infections from antibiotic-resistant bacteria are listed as serious, and three as concerning. For each bacteria threat, the CDC offers guidance for what healthcare industry officials, medical professionals and the general public can do to limit its spread.

Infections by antibiotic-resistant bacteria add as much as $20 billion in excess direct health-care costs, with additional costs for lost productivity as high as $35 billion a year, according to the report.

In its report, the CDC outlined a four-pronged strategy for combating antibiotic-resistant bacteria:

  • Preventing infections and preventing the spread of resistance.
  • Tracking resistant bacteria.
  • Improving the use of existing antibiotics.
  • Promoting the development of new antibiotics and new diagnostic tests for resistant bacteria.

“As different as these problems are, the same strategies to address them are shared in common,” Solomon said. “By helping people understand that those four core strategies are shared among the ways we address all of these antibiotic-resistant bacteria, we put it all in context and provide a glimpse of the big picture.”

Dr. Georges Benjamin, executive director of the American Public Health Association, said he appreciates the report’s frank, down-to-earth manner.

“[The report] gives us a handle. Something we can use to talk with the public,” he said. “Obviously, there is an enormous risk to the health of the public by antibiotic resistance, and it’s going to take a multiple-sector response to resolving it.”